Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.19
+0.37 (5.43%)
At close: May 12, 2025, 4:00 PM
7.20
0.00 (0.07%)
After-hours: May 12, 2025, 4:05 PM EDT
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 9.18, with a low estimate of 8.00 and a high estimate of 14.5. The average target predicts an increase of 27.68% from the current stock price of 7.19.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 7 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $10 → $8.6 | Hold | Maintains | $10 → $8.6 | +19.61% | May 9, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $9.5 → $8 | Hold | Maintains | $9.5 → $8 | +11.27% | Apr 11, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $9.5 | Hold | Maintains | $10 → $9.5 | +32.13% | Mar 13, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $8.4 → $10 | Hold | Maintains | $8.4 → $10 | +39.08% | Mar 3, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +101.67% | Dec 31, 2024 |
Financial Forecast
Revenue This Year
232.08M
from 209.36M
Increased by 10.85%
Revenue Next Year
255.44M
from 232.08M
Increased by 10.07%
EPS This Year
-0.85
from -0.90
EPS Next Year
-0.71
from -0.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 240.9M | 269.9M | 296.8M |
| Avg | 232.1M | 255.4M | 277.6M |
| Low | 222.1M | 240.2M | 258.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 15.1% | 16.3% | 16.2% |
| Avg | 10.9% | 10.1% | 8.7% |
| Low | 6.1% | 3.5% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.82 | -0.66 | -0.16 |
| Avg | -0.85 | -0.71 | -0.58 |
| Low | -0.93 | -0.79 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.